Hyderabad: The phase-2 clinical trial of the indigenously developed Covaxin began on Tuesday in Nagpur.
Bharat Biotech, the Hyderabad-based firm behind it, is testing the vaccine at Nagpur’s Gillurkar Hospital. In the first phase, 55 volunteers had undergone the test.
None of the volunteers reported any complication after the first dose. The vaccine trial will continue with a gap of 28 days, 42 days, 104 days and 194 days. The blood samples will be checked for growth in antibodies after each dose.
Bhubaneswar: A statement reportedly made by Kendrapada Collector Smruti Ranjan Pradhan regarding backwardness in the…
Bhubaneswar: The Odisha Vigilance sleuths on Monday apprehended Dr Ashok Das, consultant O&G (clinical)-cum- Joint…
New Delhi: An image of a gold-coloured Rs 7 coin featuring cricketer Mahendra Singh Dhoni…
Bhubaneswar/Puri: Amid concerns over delay in Ratna Bhandar's repair work even after the end of…
Imphal: The National Investigation Agency (NIA) has taken charge of probing three key cases related…
New Delhi: The once elusive Aamir Khan has become more visible in the past few…
Bhubaneswar: Vigilance officials on Monday unearthed huge assets including two palatial buildings, four plots and…
Bhubaneswar: The 10th National Children’s Literary Festival 2024 at KIIT International School began on a…